Henry J. Fuchs, Director at Mirati Therapeutics, Inc. (MRTX), sold 13,090 shares at $105.80 ($1.4M) on 2022-02-11, disclosed to the SEC on 2022-02-14.
Open-market sale of $1.4M MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.76 | 2,090 | $219K | 15.9% |
| 2 | $104.76 | 2,090 | $219K | 15.9% |
| 3 | $105.80 | 8,700 | $920K | 66.7% |
| 4 | $106.34 | 210 | $22K | 1.6% |
| Total | $105.48 avg | 13,090 | $1.4M | 100% |
| Filing → |
| MRTX | SELL | 2020-12-16 | $4.7M | — | Filing → |
| MRTX | SELL | 2020-08-11 | $1.6M | — | Filing → |
| BMRN | SELL | 2020-07-22 | $16.4M | — | Filing → |